This work reports the synthesis of molybdenum nanoparticles (Mo NPs) through green routes using horse gram seed extracts and characterized by GC-MS, electronic (UV-visible) spectroscopy, IR, XRD and SEM techniques. Their potent applications as in vitro anticancer agent against HeLa cell lines and photocatalytic degradation of methyl orange (MO) and methyl violet (MV) dyes were also evaluated. The anti-malignant properties of Schiff base ligands [2-fluorobenzaldehyde semicarbazone (L1H) and 2-fluorobenzaldehyde thiosemicarbazone (L2H) with molybdenum metal precursor [dioxobis(2,4-pentanedionato)molybdenum] were also explored and their Mo complexes after conversion into nano form as both ligands, L1H and L2H approve their binding property based on molecular docking studies.
No takes yet. Share an insight, caveat, or question.
Kutikanti et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: